Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis ; volume:1 ; number:1 ; day:26 ; month:10 ; year:1999 ; pages:1-11 ; date:6.1999
Arthritis Research & Therapy ; 1, Heft 1 (26.10.1999), 1-11, 6.1999
- Urheber
-
Joosten, Leo AB
- Beteiligte Personen und Organisationen
-
Lubberts, Erik
Helsen, Monique MA
Saxne, Tore
Coenen-de Roo, Christina JJ
Heinegård, Dick
van den Berg, Wim B.
SpringerLink (Online service)
- DOI
-
10.1186/ar14
- URN
-
urn:nbn:de:1111-2016050240302
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Joosten, Leo AB
- Lubberts, Erik
- Helsen, Monique MA
- Saxne, Tore
- Coenen-de Roo, Christina JJ
- Heinegård, Dick
- van den Berg, Wim B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis
Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
Perforin deficiency attenuates collagen-induced arthritis
Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis
Neuraminidase inhibitor zanamivir ameliorates collagen-induced arthritis
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
Collagen-Induced Platelet Aggregation: Involvement of Endogenous Phosphorylation
Cartilage destruction by matrix degradation products
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
Therapeutic effects of dracocephalum heterophyllum in collagen-induced arthritis
Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis
Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
Perforin deficiency attenuates collagen-induced arthritis
Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis
Neuraminidase inhibitor zanamivir ameliorates collagen-induced arthritis
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
Collagen-Induced Platelet Aggregation: Involvement of Endogenous Phosphorylation
Cartilage destruction by matrix degradation products
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
Therapeutic effects of dracocephalum heterophyllum in collagen-induced arthritis
Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis
Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
Perforin deficiency attenuates collagen-induced arthritis
Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis
Neuraminidase inhibitor zanamivir ameliorates collagen-induced arthritis
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
Collagen-Induced Platelet Aggregation: Involvement of Endogenous Phosphorylation
Cartilage destruction by matrix degradation products
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4